Washington: Max Planck scientists have identified a potential new target to fight multidrug-resistant bacteria: the factor EF-P.EF-P plays a crucial role in the production of proteins that are essential for the virulence of EHEC or salmonellae.The findings from scientist at the Max Planck Institute for Biophysical Chemistry in Gottingen suggest that drugs blocking EF-P would impair the fitness of pathogenic bacteria and might lead to a new generation of specific antibiotics that may help combat infections caused by drug-resistant pathogens.Bacteria in hospitals can pose a major risk to patients: According to estimates of the Robert Koch Institute in Berlin, up to 600,000 people in Germany alone contract a bacterial infection there every year; 15,000 of them die from the infection.
Officer dies in mishap on INS Kolkata
Jagdambika Pal resigns from Congress
SC rejects Sahara`s refund proposal
Doctors` strike: Has someone from your family died? Mulayam asks mediamen